Elixinol Wellness Limited (ASX:EXL)

Australia · Delayed Price · Currency is AUD

0.0100

+0.0010 (11.11%)

Mar 4, 2026, 3:46 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Sale of Nutraceutical and Related Hemp Products	14.96M	8.27M	7.10M	9.34M	15.01M
Sale of Nutraceutical and Related Hemp Products Growth	80.87%	16.43%	-23.95%	-37.79%	-51.13%
Total	14.96M	8.27M	7.10M	9.34M	15.01M
Total Growth	80.87%	16.43%	-23.95%	-37.79%	-51.13%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Americas	2.05M	2.64M	3.32M	4.78M	8.51M
Americas Growth	-22.21%	-20.49%	-30.63%	-43.80%	-65.84%
Australia	12.86M	5.59M	3.69M	4.09M	4.16M
Australia Growth	130.14%	51.37%	-9.67%	-1.68%	17.70%
Rest of The World	46.00K	44.00K	46.00K	469.00K	-
Rest of The World Growth	4.55%	-4.35%	-90.19%	-	-
Europe	-	-	-	-	2.34M
Europe Growth	-	-	-	-	3.35%
Total	14.96M	8.27M	7.06M	9.34M	15.01M
Total Growth	80.87%	17.21%	-24.45%	-37.79%	-51.13%

Source: S&P Global Market Intelligence.